newsfilter
← Latest News
GlobeNewswire·

BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001

VANCOUVER, British Columbia, Jan. 20, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of 2nd-generation non-hallucinog